Recent Updates
Recently added Catalysts
AMGN

Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference Amgen (NASDAQ:AMGN) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012, at...

Key Takeaway: THOUSAND OAKS, Calif. , Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012 , at the Westin St. Francis in San Francisco , Calif. Robert A. Bradway , preside

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012 , at the Westin St. Francis in San Francisco , Calif. Robert A. Bradway , president and chief operating officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Arvind Sood , 805-447-1060 (investors)
Last updated: Jan 4, 2012